A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Update Il y a 5 ans
Reference: EUCTR2014-005000-19

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy of ustekinumab as measured by a reduction in disease activity for subjects with active SLE


Inclusion criteria

  • Systemic Lupus Erythematosus